深圳康哲药业（CMSH）

名称：China Medical System Holdings Limited

行业：医药

融资金额：1000万英镑

业务及AIM上市概要：

　　CMS集团，是一家以医药为核心的中国高科技集团公司，主要从事自主知识产权的新药及医疗器械产品的开发、生产、销售、进口药品代理等业务。上市公司注册地为开曼（Cayman）。

　　深圳康哲药业现拥有已获得国家药物临床研究批件的一类新药；优秀的自产、代理品种群和覆盖中国的销售推广网络；已投放市场的获国家发明专利的医疗器械；通过GMP认证的药品生产基地。

　　CMS作为中国医药类集团，于伦敦当地时间2007年6月26日正式挂牌伦交所高增长板（London Stock Exchange AIM），实施上市交易（交易代码：CMSH）,按照每股1.38英镑的股价，总共发行7246376股，集团融资总额达1,000万英镑，而上市后按发行价计算集团市值也将达到6,520万英镑，发行市盈率为18.8倍。集团净收入之大部分将被用于集团医药产品与医疗器械的研发和生产等，及员工福利的进一步提高，以促进集团的发展。集团于二零一零年九月二十八日转到香港联合交易所主板市场上市（股份编号：867）。

China Medical System Holdings Limited

Industry: Pharmacy and Medicine

　　China Medical System Holdings Limited (“CMS”, together with its subsidiaries, the "Group") is a pharmaceutical services provider based in China, focusing on marketing promotion and sales of prescription drugs to all therapeutic departments in hospitals.

　　The Group was established in 1995, and was listed on AIM in London (ticker: CMSH) on June 26, 2007. With a price of 1.38 GBP per share, the group issued totally a number of 7,246,376 shares with a total money-raised value reaching 10 million GBP. After listed, the market capitalization of CMS reached 65.2 million GBP based on the issuance price with a price earning ratio reaching 18.8 times. The Group was listed on Main Board Market in Hong Kong on 28 September 2010 (HKEx-GEM: 867).